With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|
|Targeting the Accomplices of MYC in MYC-driven Medulloblastoma||Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D.||Innovation Grants||2014||California|
|The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2014||Pennsylvania|
|Therapies for SHH-subtype Medulloblastoma||Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, M.D.||Innovation Grants||2014||Maryland|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing||University of Massachusetts Medical School / Peter Newburger, M.D.||Innovation Grants||2014||Massachusetts|
|Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma||Dana-Farber Cancer Institute / Thomas Look, M.D.||Innovation Grants||2014||Massachusetts|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|